1,358
Views
22
CrossRef citations to date
0
Altmetric
Research Paper

The intentions to get vaccinated against influenza and actual vaccine uptake among diabetic patients in Ningbo, China: identifying motivators and barriers

, , , , , , , , & ORCID Icon show all
Pages 106-118 | Received 06 Jan 2020, Accepted 13 Apr 2020, Published online: 27 May 2020

References

  • Chan JC, Zhang Y, Ning G. Diabetes in China: a societal solution for a personal challenge. Lancet Diabetes Endocrinol. 2014;2:969–79. doi:10.1016/S2213-8587(14)70144-5.
  • Wang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q, Li Y, Zhao Z, Qin X, Jin D, et al. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA. 2017;317:2515–23. doi:10.1001/jama.2017.7596.
  • Pan XR, Yang WY, Li GW, Liu J. Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care. 1997;20:1664–69. doi:10.2337/diacare.20.11.1664.
  • Yang J, Jit M, Leung KS, Zheng YM, Feng LZ, Wang LP, Lau EH, Wu JT, Yu HJ. The economic burden of influenza-associated outpatient visits and hospitalizations in China: a retrospective survey. Infect Dis Poverty. 2015;4:44. doi:10.1186/s40249-015-0077-6.
  • World Health Organization. Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rec. 2012; 87: 461–76.
  • Feng L, Yang P, Zhang T, Yang J, Fu C, Qin Y, Zhang Y, Ma C, Liu Z, Wang Q, et al. Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015). Hum Vaccin Immunother. 2015;11:2077–101. doi:10.1080/21645515.2015.1027470.
  • Frasca D, Diaz A, Romero M, Mendez NV, Landin AM, Ryan JG, Blomberg BB. Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine. VACCINE. 2013;31:3603–10. doi:10.1016/j.vaccine.2013.05.003.
  • Wang IK, Lin CL, Chang YC, Lin PC, Liang CC, Liu YL, Chang CT, Yen TH, Huang CC, Sung FC. Effectiveness of influenza vaccination in elderly diabetic patients: a retrospective cohort study. VACCINE. 2013;31:718–24. doi:10.1016/j.vaccine.2012.11.017.
  • Lau D, Eurich DT, Majumdar SR, Katz A, Johnson JA. Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study. THORAX. 2013;68:658–63. doi:10.1136/thoraxjnl-2012-203109.
  • Vamos EP, Pape UJ, Curcin V, Harris MJ, Valabhji J, Majeed A, Millett C. Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes. CMAJ. 2016;188:E342–51. doi:10.1503/cmaj.151059.
  • Rodriguez-Blanco T, Vila-Corcoles A, de Diego C, Ochoa-Gondar O, Valdivieso E, Bobe F, Morro A, Hernandez N, Martin A, Calamote F, et al. Relationship between annual influenza vaccination and winter mortality in diabetic people over 65 years. Hum Vaccin Immunother. 2012;8:363–70. doi:10.4161/hv.18548.
  • Yang J, Atkins KE, Feng L, Pang M, Zheng Y, Liu X, Cowling BJ, Yu H. Seasonal influenza vaccination in China: landscape of diverse regional reimbursement policy, and budget impact analysis. VACCINE. 2016;34:5724–35. doi:10.1016/j.vaccine.2016.10.013.
  • Yi B, Zhou S, Song Y, Chen E, Lao X, Cai J, Greene CM, Feng L, Zheng J, Yu H, et al. Innovations in adult influenza vaccination in China, 2014-2015: leveraging a chronic disease management system in a community-based intervention. Hum Vaccin Immunother. 2018;14:947–51. doi:10.1080/21645515.2017.1403704.
  • Wu S, Su J, Yang P, Zhang H, Li H, Chu Y, Hua W, Li C, Tang Y, Wang Q. Factors associated with the uptake of seasonal influenza vaccination in older and younger adults: a large, population-based survey in Beijing, China. BMJ Open. 2017;7:e17459. doi:10.1136/bmjopen-2017-017459.
  • Ma Y, Li T, Chen W, Chen J, Li M, Yang Z. Knowledge, Attitudes and Practices (KAP) toward seasonal influenza vaccine among young workers in South China. Hum Vaccin Immunother. 2018;14:1283–93. doi:10.1080/21645515.2017.1423157.
  • Ye C, Zhu W, Yu J, Li Z, Hu W, Hao L, Wang Y, Xu H, Sun Q, Zhao G. Low coverage rate and awareness of influenza vaccine among older people in Shanghai, China: A cross-sectional study. Hum Vaccin Immunother. 2018:1–7. doi:10.1080/21645515.2018.1491246.
  • Verger P, Cortaredona S, Pulcini C, Casanova L, Peretti-Watel P, Launay O. Characteristics of patients and physicians correlated with regular influenza vaccination in patients treated for type 2 diabetes: a follow-up study from 2008 to 2011 in southeastern France. Clin Microbiol Infect. 2015;21:930–31. doi:10.1016/j.cmi.2015.06.017.
  • Jimenez-Trujillo I, Lopez-de AA, Hernandez-Barrera V, Carrasco-Garrido P, Santos-Sancho JM, Jimenez-Garcia R. Influenza vaccination coverage rates among diabetes sufferers, predictors of adherence and time trends from 2003 to 2010 in Spain. Hum Vaccin Immunother. 2013;9:1326–32. doi:10.4161/hv.23926.
  • Villarroel MA, Vahratian A. Vaccination coverage among adults with diagnosed diabetes: United States, 2015. NCHS Data Brief. 2016;265:1–8.
  • Wang Q, Yue N, Zheng M, Wang D, Duan C, Yu X, Zhang X, Bao C, Jin H. Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China: A meta-analysis. VACCINE. 2018;36:7262–69. doi:10.1016/j.vaccine.2018.10.045.
  • Wagner AL, Montgomery JP, Xu W, Boulton ML. Influenza vaccination of adults with and without high-risk health conditions in China. J Public Health (Oxf). 2017;39:358–65. doi:10.1093/pubmed/fdw041.
  • Fan J, Cong S, Wang N, Bao H, Wang B, Feng Y, Lv X, Zhang Y, Zha Z, Yu L, et al. Influenza vaccination rate and its association with chronic diseases in China: results of a national cross-sectional study. VACCINE. 2020;38:2503–11. doi:10.1016/j.vaccine.2020.01.093.
  • Ren X, Geoffroy E, Tian K, Wang L, Feng L, Feng J, Qin Y, Wu P, Zhang S, Geng M, et al. Knowledge, Attitudes, and Behaviors (KAB) of influenza vaccination in China: a cross-sectional study in 2017/2018. Vaccines (Basel). 2019:8. doi:10.3390/vaccines8010007.
  • Wang C, Li Y, Feng W, Liu K, Zhang S, Hu F, Jiao S, Lao X, Ni H, Xu G. Epidemiological features and forecast model analysis for the morbidity of influenza in Ningbo, China, 2006-2014. Int J Environ Res Public Health. 2017:14. doi:10.3390/ijerph14060559.
  • Ye L, Chen J, Fang T, Cui J, Li H, Ma R, Sun Y, Li P, Dong H, Xu G. Determinants of healthcare workers’ willingness to recommend the seasonal influenza vaccine to diabetic patients: A cross-sectional survey in Ningbo, China. Hum Vaccin Immunother. 2018:1–8. doi:10.1080/21645515.2018.1496767.
  • Seo J, Lim J. Trends in influenza vaccination coverage rates in South Korea from 2005 to 2014: effect of public health policies on vaccination behavior. VACCINE. 2018;36:3666–73. doi:10.1016/j.vaccine.2018.05.024.
  • MacDonald NE. Vaccine hesitancy: definition, scope and determinants. VACCINE. 2015;33:4161–64. doi:10.1016/j.vaccine.2015.04.036.
  • Schmid P, Rauber D, Betsch C, Lidolt G, Denker ML. Barriers of Influenza vaccination intention and behavior - a systematic review of influenza vaccine hesitancy, 2005-2016. PLoS One. 2017;12:e170550. doi:10.1371/journal.pone.0170550.
  • Betsch C, Bohm R, Chapman GB. Using behavioral insights to increase vaccination policy effectiveness. Policy Insights Behav Brain Sci. 2:61–73.
  • Coe AB, Gatewood SB, Moczygemba LR, Goode JV, Beckner JO. The use of the health belief model to assess predictors of intent to receive the novel (2009) H1N1 influenza vaccine. Innov Pharm. 2012;3:1–11. doi:10.24926/iip.v3i2.257.
  • Malosh R, Ohmit SE, Petrie JG, Thompson MG, Aiello AE, Monto AS. Factors associated with influenza vaccine receipt in community dwelling adults and their children. VACCINE. 2014;32:1841–47. doi:10.1016/j.vaccine.2014.01.075.
  • Yu MC, Chou YL, Lee PL, Yang YC, Chen KT. Influenza vaccination coverage and factors affecting adherence to influenza vaccination among patients with diabetes in Taiwan. Hum Vaccin Immunother. 2014;10:1028–35. doi:10.4161/hv.27816.
  • Santos AJ, Kislaya I, Machado A, Nunes B. Beliefs and attitudes towards the influenza vaccine in high-risk individuals. Epidemiol Infect. 2017;145:1786–96. doi:10.1017/S0950268817000814.
  • Wendlandt R, Cowling BJ, Chen Y, Havers F, Shifflett P, Song Y, Zhang R, Iuliano D, Xu C, Yu H, et al. Knowledge, attitudes and practices related to the influenza virus and vaccine among older adults in Eastern China. VACCINE. 2018;36:2673–82. doi:10.1016/j.vaccine.2018.03.052.
  • Jones CL, Jensen JD, Scherr CL, Brown NR, Christy K, Weaver J. The Health Belief Model as an explanatory framework in communication research: exploring parallel, serial, and moderated mediation. Health Commun. 2015;30:566–76. doi:10.1080/10410236.2013.873363.
  • Li Y, Ren D, Ding P, Zhang Q, Zhang J, Shi W, Wu J, Shi X, Liang X. Evaluation on programs regarding the community-based management of hypertension and type 2 diabetes mellitus patients in eight provinces, China. Zhonghua Liu Xing Bing Xue Za Zhi. 2014;35:35–39.
  • Dos SG, Tahrat H, Bekkat-Berkani R. Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: A systematic review. Hum Vaccin Immunother. 2018;14:1853–66. doi:10.1080/21645515.2018.1446719.
  • Li L, Liu Y, Wu P, Peng Z, Wang X, Chen T, Wong J, Yang J, Bond HS, Wang L, et al. Influenza-associated excess respiratory mortality in China, 2010-15: a population-based study. Lancet Public Health. 2019;4:e473–81. doi:10.1016/S2468-2667(19)30163-X.
  • Lehmann BA, Ruiter R, Chapman G, Kok G. The intention to get vaccinated against influenza and actual vaccination uptake of Dutch healthcare personnel. VACCINE. 2014;32:6986–91. doi:10.1016/j.vaccine.2014.10.034.
  • Maurer J. Inspecting the Mechanism: A Longitudinal Analysis of Socioeconomic Status Differences in Perceived Influenza Risks, Vaccination Intentions, and Vaccination Behaviors during the 2009-2010 Influenza Pandemic. Med Decis Making. 2016;36:887–99. doi:10.1177/0272989X15608379.
  • Martinez-Huedo MA, Lopez-de-Andres A, Mora-Zamorano E, Hernandez-Barrera V, Jimenez-Trujillo I, Zamorano-Leon JJ, Jimenez-Garcia R. Decreasing influenza vaccine coverage among adults with high-risk chronic diseases in Spain from 2014 to 2017. Hum Vaccin Immunother. 2019. doi:10.1080/21645515.2019.1646577.
  • Loerbroks A, Stock C, Bosch JA, Litaker DG, Apfelbacher CJ. Influenza vaccination coverage among high-risk groups in 11 European countries. Eur J Public Health. 2012;22:562–68. doi:10.1093/eurpub/ckr094.
  • Goeijenbier M, van Sloten TT, Slobbe L, Mathieu C, van Genderen P, Beyer W, Osterhaus A. Benefits of flu vaccination for persons with diabetes mellitus: A review. VACCINE. 2017;35:5095–101. doi:10.1016/j.vaccine.2017.07.095.
  • Gorska-Ciebiada M, Saryusz-Wolska M, Ciebiada M, Loba J. Pneumococcal and seasonal influenza vaccination among elderly patients with diabetes. Postepy Hig Med Dosw (Online). 2015;69:1182–89. doi:10.5604/17322693.1176772.
  • Ye L, Fang T, Ma R. Spatial clustering of services of adult vaccination clinics in Ningbo city of Zhejiang province. Chin J Vaccines Immunization. 2018;24:89–94.
  • Huang M, Zhang H, Gu Y, Wei J, Gu S, Zhen X, Hu X, Sun X, Dong H. Outpatient health-seeking behavior of residents in Zhejiang and Qinghai Province, China. BMC Public Health. 2019;19:967. doi:10.1186/s12889-019-7305-0.
  • Zhang Y, Muscatello DJ, Wang Q, Yang P, Wu J, MacIntyre CR. Overview of influenza vaccination policy in Beijing, China: current status and future prospects. J Public Health Policy. 2017;38:366–79. doi:10.1057/s41271-017-0079-7.
  • Yuen CY, Dodgson JE, Tarrant M. Perceptions of Hong Kong Chinese women toward influenza vaccination during pregnancy. VACCINE. 2016; 34:33–40. doi:10.1016/j.vaccine.2015.11.032.
  • Shi J, Tang Z, Yu W. Status and countermeasures of vaccine hesitancy. Chin J Vaccines Immunization. 2019;25:481–86.
  • Hu Y, Li Q, Lin L, Chen E, Chen Y, Qi X. Surveillance for adverse events following immunization from 2008 to 2011 in Zhejiang Province, China. Clin Vaccine Immunol. 2013;20:211–17. doi:10.1128/cvi.00541-12.
  • Yuan X, Wang R, Fu Y, Xie K, Ni W, Xu J. The analysis of knowledge-attitude-practice (KAP) and influencing factors of influenza vaccination in type 2 diabetes mellitus (T2DM) patients. Chin J Prev Control Chron Dis. 2018;26:905–09.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.